Aims: Polyphenolic chemicals, such as quercetin and curcumin have anti-cancer properties due to their antioxidant and anti-inflammatory properties. Quercetin and curcumin aids in detoxification by boosting enzyme function and eliminating free radicals. We aimed to conduct a detailed meta-analysis of research articles reporting the protective effects of curcumin and quercetin in cancer studies.
Methods: The study was selected all studies over time carried out to date within the framework of our concept ,using various medical subject headings and databases like Elsevier, National Library of Frontiers, ResearchGate, Scopus Medicine, and Google Scholar. PRISMA guidelines was performed. The data management system played a significant role in locating and evaluating relevant articles, ensuring the accuracy and precision of the findings.
Results: From a total of 85 articles accessed in this analysis, 4 studies on quercetin and 3 studies on curcumin were included. The analyzed studies show that quercetin and curcumin have anti-cancer benefits through various cellular pathways. Quercetin inhibits Twist in breast cancer cells, while curcumin reduces Akt/mTOR cellular signaling, enhances Bax expression, and triggers cell death. It also prevents cell growth in human lung cancer cells and bladder cancer. Curcumin control reactive oxygen species levels, inhibit cancer cell proliferation, and stimulate apoptotic pathways. They also influence cancer development by altering cellular signaling pathways and affecting non-coding RNAs.
Conclusion: Our meta-analysis reports that quercetin and curcumin have the potential to be used in the treatment and prevention of cancer, it may be useful to investigate their synergistic effects.
This material is the authors' own original work, which has not been previously published elsewhere.
None
None
None
None
Primary Language | English |
---|---|
Subjects | Nutrition and Dietetics (Other) |
Journal Section | Original Article |
Authors | |
Project Number | None |
Publication Date | May 27, 2024 |
Submission Date | March 18, 2024 |
Acceptance Date | May 11, 2024 |
Published in Issue | Year 2024 Volume: 7 Issue: 3 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.